AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
318: Drug pricing drops & psychedelics under fire
The Readout Loud
Challenges in Psychedelic Drug Development and Regulatory Setbacks
This chapter explores the hurdles companies face in using psychedelics for mental health treatments, including the FDA's rejection of an MDMA-assisted therapy by Lycos Therapeutics. It also discusses the retraction of associated research papers, highlighting the difficulties in the evolving psychedelic drug development landscape.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode